QIAstat-Dx Syndromic Testing

About Qiagen

QIAGEN operates as a Sample to Insight company, providing integrated solutions that transform biological samples into valuable molecular insights. With a focus on molecular diagnostics and life sciences research, the company serves clinical laboratories, academic institutions, pharmaceutical and biotechnology companies worldwide. QIAGEN's product portfolio spans the entire sample-to-insight workflow, from sample collection and preparation to assay development, automation, and data analysis. The company is publicly traded on NASDAQ under the ticker QGEN and is headquartered in the Netherlands.

Therapeutic Areas